Biallelic pathogenic variants in either HARS2 (mtARS for histidine) or LARS2 (mtARS for leucine) result in Perrault syndrome, which associates HI with ovarian dysfunction in females, and manifests as NSHI in males [8,9]. Here, LARS2 is linked to Perrault syndrome.